Sorafenib Drug Drug Interaction Study in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

September 30, 2015

Conditions

Drug Interactions

Interventions

DRUG

Sorafenib (Nexavar, BAY43-9006)

Single dose of 400 mg orally on Period 1 Day 1 and Period 2 Day 11

DRUG

Levothyroxine

Single dose of 300 mcq orally from Period 2 Day 1 to Period 2 Day 14

Trial Locations (1)

Berlin